[
  {
    "ts": "2025-12-24T00:14:35+00:00",
    "headline": "Arcellx (ACLX) Valuation Check After Wells Fargo Launches Coverage on Its Multiple Myeloma CAR‑T Program",
    "summary": "Wells Fargo just kicked off coverage on Arcellx (ACLX), zeroing in on its experimental CAR T therapy for multiple myeloma as a potential future treatment backbone and putting the company more firmly on investors radar. See our latest analysis for Arcellx. That call from Wells Fargo lands after a choppy stretch, with a 1 month share price return of minus 27.36% and a year to date share price return of minus 16.81%. However, the 3 year total shareholder return is still up 121.17%, suggesting...",
    "url": "https://finance.yahoo.com/news/arcellx-aclx-valuation-check-wells-001435700.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "baaa1d7b-e08d-335c-8ed9-c1b4a995789f",
      "content": {
        "id": "baaa1d7b-e08d-335c-8ed9-c1b4a995789f",
        "contentType": "STORY",
        "title": "Arcellx (ACLX) Valuation Check After Wells Fargo Launches Coverage on Its Multiple Myeloma CAR‑T Program",
        "description": "",
        "summary": "Wells Fargo just kicked off coverage on Arcellx (ACLX), zeroing in on its experimental CAR T therapy for multiple myeloma as a potential future treatment backbone and putting the company more firmly on investors radar. See our latest analysis for Arcellx. That call from Wells Fargo lands after a choppy stretch, with a 1 month share price return of minus 27.36% and a year to date share price return of minus 16.81%. However, the 3 year total shareholder return is still up 121.17%, suggesting...",
        "pubDate": "2025-12-24T00:14:35Z",
        "displayTime": "2025-12-24T00:14:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/I2k3PKJsWIEX9xgEQz8JwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tmSjpFKmBAT61w1lG5.BLQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/arcellx-aclx-valuation-check-wells-001435700.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/arcellx-aclx-valuation-check-wells-001435700.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ACLX"
            },
            {
              "symbol": "WFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]